Literature DB >> 24436516

Transhepatic therapies for metastatic uveal melanoma.

David J Eschelman1, Carin F Gonsalves1, Takami Sato2.   

Abstract

Despite successful treatment of the primary tumor, uveal melanoma has a propensity to metastasize to the liver. Prognosis is poor due to the very aggressive nature of these tumors. Because systemic therapies are relatively ineffective and patient survival correlates to disease control in the liver, locoregional therapies provide a means of prolonging survival. We review various techniques including chemoembolization, immunoembolization, radioembolization, arterial fotemustine infusion, and hepatic perfusion for the treatment of liver metastases from uveal melanoma.

Entities:  

Keywords:  chemoembolization; immunoembolization; liver metastases; radioembolization; uveal melanoma

Year:  2013        PMID： 24436516      PMCID： PMC3700787          DOI： 10.1055/s-0033-1333652

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  41 in total

1.  Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.

Authors:  T Yoshida; M Sakon; K Umeshita; T Kanai; A Miyamoto; T Takeda; M Gotoh; H Nakamura; K Wakasa; M Monden
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

2.  Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.

Authors:  S Leyvraz; V Spataro; J Bauer; S Pampallona; R Salmon; T Dorval; R Meuli; M Gillet; F Lejeune; L Zografos
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

3.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors:  Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

4.  Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.

Authors:  Carin F Gonsalves; David J Eschelman; Kevin L Sullivan; P Rani Anne; Laura Doyle; Takami Sato
Journal:  AJR Am J Roentgenol       Date:  2011-02       Impact factor: 3.959

Review 5.  Locoregional management of hepatic metastasis from primary uveal melanoma.

Authors:  Takami Sato
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

6.  Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.

Authors:  Sanjay Gupta; Agop Y Bedikian; Judy Ahrar; Joe Ensor; Kamran Ahrar; David C Madoff; Michael J Wallace; Ravi Murthy; Alda Tam; Patrick Hwu
Journal:  Am J Clin Oncol       Date:  2010-10       Impact factor: 2.339

7.  Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.

Authors:  S Peters; V Voelter; L Zografos; S Pampallona; R Popescu; M Gillet; W Bosshard; G Fiorentini; M Lotem; R Weitzen; U Keilholz; Y Humblet; S Piperno-Neumann; R Stupp; S Leyvraz
Journal:  Ann Oncol       Date:  2006-02-09       Impact factor: 32.976

8.  Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.

Authors:  A Y Bedikian; S S Legha; G Mavligit; C H Carrasco; S Khorana; C Plager; N Papadopoulos; R S Benjamin
Journal:  Cancer       Date:  1995-11-01       Impact factor: 6.860

9.  New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.

Authors:  T Kanai; M Monden; M Sakon; M Gotoh; K Umeshita; Y Hasuike; H Nakano; T Monden; T Murakami; H Nakamura
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Locoregional treatment of malignant hepatic tumors with biologic response modifiers.

Authors:  Akira Yamamoto; Takami Sato
Journal:  Surg Oncol Clin N Am       Date:  2008-10       Impact factor: 3.495
View more
  16 in total

1.  Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.

Authors:  Philippe L Pereira; Kristina Krüger; Ernst Hohenstein; Florian Welke; Christof Sommer; Friedegund Meier; Thomas Eigentler; Claus Garbe
Journal:  Eur Radiol       Date:  2017-11-09       Impact factor: 5.315

2.  Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma.

Authors:  Ryan Sangwoo Kim; Patricia Chevez-Barrios; Mukul Divatia; Maria Eugenia Bretana; Bin Teh; Amy Claire Schefler
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

3.  Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases.

Authors:  Kevin M Halenda; Ragini R Kudchadkar; David H Lawson; Darren D Kies; Kristen E Zhelnin; Alyssa M Krasinskas; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2015-12-24

4.  Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Authors:  Brian A Boone; Samantha Perkins; Rupal Bandi; Ernesto Santos; Kevin McCluskey; David L Bartlett; James F Pingpank
Journal:  J Surg Oncol       Date:  2018-04       Impact factor: 3.454

5.  Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.

Authors:  Jesus Vera-Aguilera; Agop Y Bedikian; Roland L Bassett; Wen-Jen Hwu; Kevin B Kim; Yong Qin; Suzanne Cain; Edwina W Washington; Michael A Davies; Sunil M Patel; Jade Homsi; Nicholas E Papadopoulos; Patrick Hwu; Sapna P Patel
Journal:  Am J Clin Oncol       Date:  2018-11       Impact factor: 2.339

6.  Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

Authors:  Lei Sun; Peng Sun; Qi-Ying Zhou; Xiangchun Gao; Qing Han
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

7.  Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Authors:  T Susanna Meijer; Lioe-Fee de Geus-Oei; Christian H Martini; Fred G J Tijl; M Elske Sitsen; Arian R van Erkel; Rutger W van der Meer; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

Review 8.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

9.  A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma.

Authors:  Juliane Schelhorn; Heike Richly; Marcus Ruhlmann; Thomas C Lauenstein; Jens M Theysohn
Journal:  Acta Radiol Open       Date:  2015-04-06

Review 10.  Uveal melanoma: estimating prognosis.

Authors:  Swathi Kaliki; Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.